265 related articles for article (PubMed ID: 18474629)
21. [Establishment of a mouse model of autoimmune hepatitis induced by human CYP2D6].
Chi G; Ma Q; Pei J; Feng Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Aug; 34(8):690-694. PubMed ID: 30384866
[TBL] [Abstract][Full Text] [Related]
22. Hepatic T Cell Tolerance Induction in An Inflammatory Environment.
Dywicki J; Noyan F; Misslitz AC; Hapke M; Galla M; Schlue J; Liblau RS; Taubert R; Manns MP; Jaeckel E; Hardtke-Wolenski M
Dig Dis; 2018; 36(2):156-166. PubMed ID: 29020680
[TBL] [Abstract][Full Text] [Related]
23. Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice.
Chi G; Pei JH; Ma QY; Ru YX; Feng ZH
Immunol Lett; 2020 Feb; 218():44-50. PubMed ID: 31794800
[TBL] [Abstract][Full Text] [Related]
24. A monoclonal antibody inhibitory to human P450 2D6: a paradigm for use in combinatorial determination of individual P450 role in specific drug tissue metabolism.
Gelboin HV; Krausz KW; Shou M; Gonzalez FJ; Yang TJ
Pharmacogenetics; 1997 Dec; 7(6):469-77. PubMed ID: 9429232
[TBL] [Abstract][Full Text] [Related]
25. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
26. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
29. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
30. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
31. L-lysine supplementation attenuates experimental autoimmune hepatitis in a chronic murine model.
Lei Y; Chen Y; Wang S; Lin Z; Han P; Tian D; Wang H; Liu M
Exp Anim; 2024 Feb; 73(1):83-92. PubMed ID: 37648521
[TBL] [Abstract][Full Text] [Related]
32. Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Baillieres Clin Gastroenterol; 1996 Sep; 10(3):501-32. PubMed ID: 8905121
[TBL] [Abstract][Full Text] [Related]
33. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
[TBL] [Abstract][Full Text] [Related]
34. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
Wang H; Feng X; Yan W; Tian D
Front Immunol; 2020; 11():575572. PubMed ID: 33117375
[TBL] [Abstract][Full Text] [Related]
35. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
[TBL] [Abstract][Full Text] [Related]
36. Animal models for autoimmune hepatitis.
Christen U; Holdener M; Hintermann E
Autoimmun Rev; 2007 Apr; 6(5):306-11. PubMed ID: 17412303
[TBL] [Abstract][Full Text] [Related]
37. Relation between post-partum liver dysfunction and anti-cytochrome 2D6 antibodies.
Izumi Y; Tanaka S; Hidaka Y; Shimaoka Y; Tatsumi KI; Takano T; Kaneko A; Oku K; Amino N
Am J Reprod Immunol; 2003 Oct; 50(4):355-62. PubMed ID: 14672341
[TBL] [Abstract][Full Text] [Related]
38. Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?
Christen U; Hintermann E; Holdener M; von Herrath MG
J Autoimmun; 2010 Feb; 34(1):38-44. PubMed ID: 19716269
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
Clemente MG; Obermayer-Straub P; Meloni A; Strassburg CP; Arangino V; Tukey RH; De Virgiliis S; Manns MP
J Clin Endocrinol Metab; 1997 May; 82(5):1353-61. PubMed ID: 9141515
[TBL] [Abstract][Full Text] [Related]
40. Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s.
Bogdanos DP; Dalekos GN
Curr Med Chem; 2008; 15(22):2285-92. PubMed ID: 18781950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
